Clinical update on the use of recombinant factor VII

This publication has 20 references indexed in Scilit:

• Experience With Recombinant Factor VIIA in an Infant Hemophiliac With Inhibitors to FVIILC Undergoing Emergency Central Line Placement
  Journal of Pediatric Hematology/Oncology, 1993
• A therapeutic alternative for haemophiliacs with inhibitors
  Acta Paediatrica, 1992
• PROLONGED RECOMBINANT ACTIVATED FACTOR VII (rFVIIa) TREATMENT FOR SEVERE BLEEDING IN A FACTOR‐IX‐DEFICIENT PATIENT WITH AN INHIBITOR
  British Journal of Haematology, 1991
• Efficacy and safety of vapor‐heated anti‐inhibitor coagulant complex in hemophilia patients. FEIBA Study Group
  Transfusion, 1990
• Factor VIIa in the treatment of haemophilia
  Blood Coagulation & Fibrinolysis, 1990
• The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experience
  Archives of internal medicine (1960), 1989
• Hematologic management of hemophilia A for surgery
  JAMA, 1985
• Use of human factor VIIa in the treatment of two hemophilia A patients with high-titer inhibitors.
  Journal of Clinical Investigation, 1983
• The Effect of Activated Prothrombin-Complex Concentrate (FEIBA) on Joint and Muscle Bleeding in Patients with Hemophilia A and Antibodies to Factor VIII
  New England Journal of Medicine, 1981
• Efficacy of Prothrombin-Complex Concentrates in Hemophiliacs with Antibodies to Factor VIII
  New England Journal of Medicine, 1980